Loading: 100%
SeaSpine Holdings Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 310 (as per Q2 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker SPNEno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170481216
datesClosing price (adj.)
13.10.201710.71
11.10.201710.95
04.10.201710.77
27.09.201710.58
20.09.201710.16
13.09.201710.94
06.09.201711.21
30.08.201711.12
23.08.201711.82
16.08.201711.93
09.08.201712.88
02.08.201711.58
26.07.201711.93
19.07.201712.02
12.07.201713.41
05.07.201711.93
27.06.201710.98
20.06.20179.94
13.06.20179.94
06.06.20179.97
30.05.201710.22
23.05.201710.73
16.05.201710.07
09.05.20178.89
02.05.20177.93
25.04.20178.73
18.04.20178.45
11.04.20177.73
04.04.20177.72
28.03.20177.13
21.03.20177.31
14.03.20176.66
07.03.20176.78
28.02.20177.09
21.02.20177.01
14.02.20176.86
07.02.20177.00
31.01.20177.28
24.01.20177.45
17.01.20177.50
10.01.20177.67
03.01.20177.56
27.12.20167.44
19.12.20167.08
12.12.20167.59
05.12.20167.50
28.11.20166.92
21.11.20167.00
14.11.20167.15
07.11.20169.37
31.10.20169.31
24.10.20169.87
17.10.20169.98
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
10.71n/a
Market Capitalisation
in million USD
120n/a
Enterprise Value
in million USD
97n/a
Common Shares Outstanding
as per Aug 2, 2016
11,205,791n/a
Preferred Shares Outstanding
as per Aug 2, 2016
n/a
Average Basic Shares Outstanding
TTM
11,213,500n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
SeaSpine Holdings Corp is a medical technology company. It focuses on design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 132n/a
Gross Profit 70n/a
Operating Income -52n/a
EBITDA 0n/a
Net Profit -52n/a
Balance Sheet
Cash and Cash Equivalents 23n/a
Receivables 23n/a
Total Current Assets 96n/a
PP&E 22n/a
Total Assets 155n/a
Accounts Payable 11n/a
Current Debt 0n/a
Total Current Liabilities 24n/a
Long-Term Debt 0n/a
Total Liabilities 28n/a
Total Equity 127n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 52.9%n/a
Operating Margin -39.6%n/a
Net Profit Margin -39.4%n/a
Return on Equity -40.8%n/a
Return on Assets -33.5%n/a
Per Share Figures
Basic EPS -4.63n/a
Diluted EPS n/a
Sales per Share 11.77n/a
Book Value per Share 11.35n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio -2.31n/a
Price to Sales Ratio 0.91n/a
Price to Book Value 0.94n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 0.74n/a
Book to Market Value 1.06n/a
Other Ratios
Current Ratio 393.8%n/a
Liabilities to Equity Ratio 21.8%n/a
Debt to Assets Ratio 0.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Revenue
147
139
133
Sales & Services Revenue
0
0
0
Financing Revenue
0
0
0
Other Revenue
0
0
0
Cost of revenue
-56
-57
-61
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
91
82
72
Other Operating Income
0
0
0
Operating Expenses
-109
-102
-124
Selling, General & Administrative
-93
-88
-111
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-10
-9
-8
Depreciation & Amortization
-6
-6
-5
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
0
0
0
Operating Income (Loss)
-17
-20
-52
Non-Operating Income (Loss)
-5
0
-1
Interest Expense, net
0
0
0
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
-5
0
-1
Pretax Income (Loss), Adjusted
-22
-21
-53
Abnormal Gains (Losses)
0
0
0
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
0
0
0
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
-22
-21
-53
Income Tax (Expense) Benefit, net
-4
-4
-2
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
-26
-25
-56
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
-26
-25
-56
Minority Interest
0
0
0
Net Income
-26
-25
-56
Preferred Dividends
0
0
0
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
-26
-25
-56
Remarks
restated on Mar 16, 2016 n/a
calculated values,
restated on Mar 16, 2016 n/a
calculated values,
restated on Mar 16, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1
33
Cash & Cash Equivalents
n/a
1
33
Short Term Investments
n/a
0
0
Accounts & Notes Receivable
n/a
23
25
Accounts Receivable, Net
n/a
23
25
Notes Receivable, Net
n/a
0
0
Unbilled Revenues
n/a
0
0
Inventories
n/a
50
51
Raw Materials
n/a
0
0
Work In Process
n/a
0
0
Finished Goods
n/a
0
0
Other Inventory
n/a
0
0
Other Short Term Assets
n/a
2
4
Prepaid Expenses
n/a
2
4
Derivative & Hedging Assets
n/a
0
0
Assets Held-for-Sale
n/a
0
0
Deferred Tax Assets
n/a
0
0
Income Taxes Receivable
n/a
0
0
Discontinued Operations
n/a
0
0
Miscellaneous Short Term Assets
n/a
0
0
Total Current Assets
n/a
75
114
Property, Plant & Equipment, Net
n/a
16
22
Property, Plant & Equipment
n/a
0
0
Accumulated Depreciation
n/a
0
0
Long Term Investments & Receivables
n/a
0
0
Long Term Investments
n/a
0
0
Long Term Marketable Securities
n/a
0
0
Long Term Receivables
n/a
0
0
Other Long Term Assets
n/a
49
41
Intangible Assets
n/a
47
40
Goodwill
n/a
0
0
Other Intangible Assets
n/a
0
0
Prepaid Expense
n/a
0
0
Deferred Tax Assets
n/a
0
0
Derivative & Hedging Assets
n/a
0
0
Prepaid Pension Costs
n/a
0
0
Discontinued Operations
n/a
0
0
Investments in Affiliates
n/a
0
0
Miscellaneous Long Term Assets
n/a
2
1
Total Noncurrent Assets
n/a
65
63
Total Assets
n/a
140
176
Liabilities and owners' equity
Payables & Accruals
n/a
46 45952000
26 26035000
Accounts Payable
n/a
37 36637000
14 13689000
Accrued Taxes
n/a
1 608000
0 0
Interest & Dividends Payable
n/a
0 0
0 0
Other Payables & Accruals
n/a
9 8707000
12 12346000
Short Term Debt
n/a
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
Total Current Liabilities
n/a
46 45952000
26 26035000
Long Term Debt
n/a
0 0
0 328000
Long Term Borrowings
n/a
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
Other Long Term Liabilities
n/a
93 92797000
3 2687000
Accrued Liabilities
n/a
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
Pensions
n/a
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
93 92797000
3 2687000
Total Noncurrent Liabilities
n/a
93 92797000
3 3015000
Total Liabilities
n/a
139 138749000
29 29050000
Preferred Equity
n/a
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
0 0
174 173897000
Common Stock
n/a
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
Other Share Capital
n/a
0 0
0 0
Treasury Stock
n/a
0 0
0 0
Retained Earnings
n/a
0 0
-28 -27949000
Other Equity
n/a
1 893000
1 1391000
Equity Before Minority Interest
n/a
1 893000
147 147339000
Minority Interest
n/a
0 0
0 0
Total Equity
n/a
1 893000
147 147339000
Total Liabilities & Equity
n/a
140 139642000
176 176389000
Remarks restated on n/a restated on Mar 16, 2016 n/a restated on Aug 10, 2016 n/a
Cash Flow StatementCF data quality: 80% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income/Starting Line
-26
-25
-56
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
14
13
12
Non-Cash Items
7
7
13
Stock-Based Compensation
0
0
0
Deferred Income Taxes
0
0
0
Other Non-Cash Adjustments
0
0
0
Change in Working Capital
-2
6
-3
(Increase) Decrease in Accounts Receivable
0
0
0
(Increase) Decrease in Inventories
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
Increase (Decrease) in Other
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
-7
1
-33
Change in Fixed Assets & Intangibles
-6
-4
-12
Disposition of Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets
0
0
0
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
0
0
0
Decrease in Long Term Investment
0
0
0
Increase in Long Term Investment
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
0
0
0
Other Investing Activities
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
-6
-4
-12
Dividends Paid
0
0
0
Cash From (Repayment of) Debt
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
Repayments of Long Term Debt
0
0
0
Cash From Long Term Debt
0
0
0
Cash From (Repurchase of) Equity
0
0
0
Increase in Capital Stock
0
0
0
Decrease in Capital Stock
0
0
0
Other Financing Activities
14
3
77
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
14
3
77
Net Cash Before Disc. Operations and FX
1
0
33
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
1
0
33
Effect of Foreign Exchange Rates
0
0
0
Net Changes in Cash
1
0
33
Remarks
restated on Mar 16, 2016 n/a
calculated values,
restated on Mar 16, 2016 n/a
calculated values,
restated on Mar 16, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo